HASAN AND SINGH Intellectuals @ Law Patents, Trademarks, Designs, Copyright & Protection of Plant Varieties ______and gain a greater share of the growing generics market. 1. ready to revamps intellectual property policy. Read More.. India is hiring 1,000 officials for its patent offices and has vowed to clear the backlog 4. Gilead enters into licenses with 7 of all pending applications over the next Indian generics for manufacture and 18 months as it seeks to defend itself sale of Sovaldi. against western allegations that it tramples has now entered into on companies‟ intellectual property rights. licensing agreements with seven Indian Read More.. generic manufacturers – , Cadila Healthcare, Hetero, Strides Arcolab, Ranbaxy, Sequent Scientific and Mylan. 2. Novartis files lawsuit against Zydus. This license allows the companies to -based Cadila Healthcare Ltd manufacture and sell the drug in any of (Zydus Cadila) is facing lawsuits in the 91 voluntary licence (VL) countries at various US courts, including one filed by their own price but at a 7% royalty rate on global pharma major Novartis any sales. Pharmaceuticals, for infringement of Read More.. patents. Novartis has filed two suits against Cadila Healthcare‟s US subsidiaries Zydus Noveltech and Zydus 5. Vringo v. ZTE- ‘Expert’ Need Not Pharmaceuticals (USA), accusing them of Have Specialised Degree. infringing patents relating to a drug that The ongoing dispute between Vringo and treats Alzheimer‟s and Parkinson‟s ZTE has yet another update by the Delhi disease. High Court- this time, on the scope of Read More.. who is an expert under S.45 of the Indian Evidence Act. It was held, “it is accepted and recognised that a person could be an 3. US drug patent expiries to benefit expert in an area of specialised knowledge Indian pharma industry. by experience and he or she need not hold Expiry of drug patents in the US is great a degree in the field of specialised news for not only consumers but also the knowledge. A person can also become an domestic , where expert by virtue of one‟s avocation or generics account for about 75 percent of occupation.” total sales, CARE Ratings said in its Read More.. report released on 11th September. Indian pharmaceutical companies have an opportunity to capitalise on the patent cliff

HASAN AND SINGH Intellectuals @ Law Patents, Trademarks, Designs, Copyright & Protection of Plant Varieties ______6. Infrastructure and Transparency get on the enforcement of their corresponding a boost at the IP Office. U.S. patent rights. Mr Amitabh Kant, Secretary, Department Read More.. of Industrial Policy and Promotion, Ministry of Commerce and Industry, recently inaugurated a new building that is 9. What the new patent law means for to be used by the Intellectual Property North Carolina businesses. Office. A new payment gateway The state of North Carolina recently integrated into the e-filing system was enacted a new law created to protect also inaugurated that provides for businesses from abusive patent trolls – payment by internet banking debit cards also known as nonpracticing entities -- etc., of over 70 banks as opposed to the that don‟t make products or provide earlier permissible 2 banks. This would services, but own patents only to pursue cover the entire series of forms and patent infringement claims. payments. Read More.. Read More..

10. Federal Circuit Falls in Line: 7. Patent Owner Cannot Assert A Supporting Strong Limits on Patent Claim That Is Missing A Material Eligibility. Limitation. In buySAFE v. Google (Fed. Cir. 2014), Addressing an attempt by a patent owner the Federal Circuit has found the to assert a patent claim that was missing a patentee‟s computer-based-transaction material limitation, the U.S. Court of patent to be invalid as an abstract idea Appeals for the Federal Circuit affirmed a lacking subject matter eligibility. The summary judgment of invalidity, finding decision by Judge Taranto and Joined by that the patentee cannot assert the claim Judge Hughes is somewhat unremarkable unless the omission is evident on the face and the holding falls easily within the of the patent. H-W Tech., L.C. v. framework created by Alice Corp and Overstock.com, Inc., Case Nos. 14-1054, - Mayo. At the same time, the Federal 105. Circuit offers several nuggets that may Read More.. provide broader fodder for future eligibility challenges.

Read More.. 8. Effect of foreign patent proceedings on U.S. patent litigation. Prosecution and litigation of patents in foreign jurisdictions may have an impact

HASAN AND SINGH Intellectuals @ Law Patents, Trademarks, Designs, Copyright & Protection of Plant Varieties ______11. U.S. court revives Microsoft co- Braun‟s patents after which Braun founder's patent suit vs tech companies. appealed to the Board of Appeals. U.S. appeals court on 10th September However, the appeal was dismissed and revived part of a patent lawsuit brought by the patents of B Braun stand revoked. Microsoft co-founder Paul Allen against Read More.. AOL, Apple, Google and Yahoo, saying a lower court incorrectly found that the tech companies didn't infringe one of its 14. Cipla grants patent rights in patents. Rifaximin Complexes family to Salix Pharma. Read More.. Cipla, a Rs.9,800 crore plus fifth largest Mumbai based pharma major, has signed 12. Govt withdraws NPPA powers to an agreement with Salix Pharmaceuticals, cap prices of non-essential medicines in Inc., a US-based speciality pharmaceutical public interest. company. Under the agreement, Cipla has The Indian Government withdrew granted Salix exclusive rights under guidelines that enabled the National certain patent applications in the Pharmaceutical Pricing Authority (NPPA) „Rifaximin Complexes‟ patent family exercise its powers to fix the prices of controlled by Cipla. drugs that are not on the essential Read More.. medicines list. It is pertinent to note that this withdrawal is prospective not retrospective; that is to say that this move 15. Software patent guidelines in the will not reverse the price caps already offing, says official. placed. The regulatory guidelines related to Read More.. patenting software, a draft of which has been issued by the Indian Patent Office, is in the stage of finalisation, even as the 13. B Braun v PolyMed: Indian Poly multinational and Indian firms are Medicure wins medical device patent debating whether the regulation is battle at EPO. required or not, said R Devan, deupty Poly Medicure (an Indian company that controller of Patents & Designs, manufactures medical devices) has won a Intellectual Property Office, Chennai. five year long patent battle against B Read More.. Braun (German medical devices and pharma giant).The patent litigation revolved around B Braun‟s patents that cover certain features of intravenous (IV) safety catheters. The EPO revoked two of